1.Hopkins, RA, Bull, C, Haworth, SG, de Leval, MR, Stark, J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628–634.
2.Wheller, J, George, BL, Mulder, DG, Jamarkani, JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979; 60: 1640–1644.
3.Wessel, DL, Adatia, I, Giglia, TM, Thompson, JE, Kulik, TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88 [part 1]: 2128–2138.
4.Komai, H, Adatia, I, Elliott, MJ, de Leval, MR, Haworth, SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993; 106: 473–478.
5.Adatia, I, Barrow, S, Stratton, P, Ritter, J, Haworth, S. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. Br Heart J 1994; 72: 452–456.
6.Bando, K, Turrentine, MW, Sharp, TG, et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 1996; 112: 1600–1607; discussion 1607–1609.
7.Lindberg, L, Olsson, AK, Jogi, P, Jonmarker, C. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 2002; 123: 1155–1163.
8.Brown, KL, Ridout, DA, Goldman, AP, Hoskote, A, Penny, DJ. Risk factors for long intensive care unit stay after cardiopulmonary bypass in children. Crit Care Med 2003; 31: 28–33.
9.Schulze-Neick, I, Li, J, Penny, DJ, Redington, AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 2001; 121: 1033–1039.
10.Hanley, F, Heinemann, M, Jonas, R, et al. Repair of truncus arteriosus in the neonate. J Thorac Cardiovasc Surg 1993; 105: 1047–1056.
11.Haworth, SG. Pulmonary vascular disease in different types of congenital heart disease. Br Heart J 1984; 52: 557–571.
12.Brizard, CP, Cochrane, A, Austin, C, Nomura, F, Karl, TR. Management strategy and long-term outcome for truncus arteriosus. Eur J Cardiothorac Surg 1997; 11: 687–695; discussion 695–686.
13.Flori, HR, Johnson, LD, Hanley, FL, Fineman, JR. Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: associated complications and outcomes. Crit Care Med 2000; 28: 2997–3001.
14.Anand, KJ, Hansen, DD, Hickey, PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 1990; 73: 661–670.
15.Anand, KJ, Sippell, WG, Aynsley-Green, A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1987; 1 (8524): 62–66.
16.Morris, K, Beghetti, M, Petros, A, Adatia, I, Bohn, D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 2000; 28: 2974–2978.
17.Chang, AC, Zucker, HA, Hickey, PR, Wessel, DL. Pulmonary vascular resistance in infants after cardiac surgery: role of carbon dioxide and hydrogen ion. Crit Care Med 1995; 23: 568–574.
18.Beghetti, M, Habre, W, Berner, M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995; 73: 65–68.
19.Miller, OI, Celermeyer, DS, Deanfield, JE, Macrae, DJ. Very low dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108: 487–494.
20.Journois, D, Pouard, P, Mauriat, P, Malhère, T, Vouhé, P, Safran, D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107: 1129–1135.
21.Russell, IA, Zwass, MS, Fineman, JR, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998; 87: 46–51.
22.Journois, D, Baufreton, C, Mauriat, P, Pouard, P, Vouhe, P, Safran, D. Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects. Chest 2005; 128: 3537–3544.
23.Wessel, DL, Adatia, I, Thompson, JE, Hickey, PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994; 22: 930–938.
24.Miller, OI, Celermajer, DS, Deanfield, JE, Macrae, DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 1994; 70: F47–F49.
25.Miller, OI, Tang, SF, Keech, A, Pigott, NB, Beller, E, Celermajer, DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000; 356: 1464–1469.
26.Day, RW, Hawkins, JA, McGough, EC, Crezee, KL, Orsmond, GS. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000; 69: 1907–1912; discussion 1913.
27.Atz, AM, Adatia, I, Wessel, DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996; 62: 1759–1764.
28.Miller, OI, Tang, SF, Keech, A, Celermajer, DS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 1995; 346 (8966): 51–52.
29.Namachivayam, P, Theilen, U, Butt, WW, Cooper, SM, Penny, DJ, Shekerdemian, LS. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 2006; 174: 1042–1047.
30.Humpl, T, Reyes, JT, Holtby, H, Stephens, D, Adatia, I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005; 111: 3274–3280.
31.Ikonomidis, JS, Hilton, EJ, Payne, K, et al. Selective endothelin-A receptor inhibition after cardiac surgery: a safety and feasibility study. Ann Thorac Surg 2007; 83: 2153–2160; discussion 2161.
32.Barr, FE, Tirona, RG, Taylor, MB, et al. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 2007; 134: 319–326.